<Table 1>
 <caption text="

         Platelet indices with their normal range and their diagnostic and prognostic value in selected conditions.
        
">
 </caption>
 <row row="0">
  <cell col="0" row="0" text="
           Platelet Indices (PI)
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="1" row="0" text="
           Normal range
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="2" row="0" text="
           Conditions with platelet indices above normal range
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="3" row="0" text="
           Conditions with platelet indices below normal range
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
 </row>
 <row row="1">
  <cell col="0" row="1" text="
           MPV
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="1" row="1" text="
           7.2-11.7 fL
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="2" row="1" text="



              -
             

              immune thrombocytopenia purpura (ITP) [
              
               45
              
              ]
             



              -
             

              diabetes mellitus [
              
               18,19
              
              ]
             



              -
             

              DM related retinopathy and nephropathy [
              
               22,23
              
              ]
             



              -
             

              skeptic shock [
              
               16
              
              ]
             



              -
             

              heart disease [
              
               25
              
              ]
             



              -
             

              malignant tumors [
              
               31
              
              ]
             



              -
             

              complicated acute appendicitis [
              
               39
              
              ]
             


">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="3" row="1" text="



              -
             

              non-complicated acute appendicitis [
              
               39
              
              ]
             



              -
             

              acute cholecystitis [
              
               40,41
              
              ]
             



              -
             

              low-grade inflammation ex. rheumatoid arthritis [
              
               11
              
              ]
             



              -
             

              threatened preterm labor [
              
               10
              
              ]
             


">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
 </row>
 <row row="2">
  <cell col="0" row="2" text="
           PDW
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="1" row="2" text="
           8.3-56.6%
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="2" row="2" text="



              -
             

              DM related retinopathy and nephropathy [
              
               22,23
              
              ]
             



              -
             

              ST-elevation myocardial infarction [
              
               25
              
              ]
             



              -
             

              acute cholecystitis [
              
               40
              
              ]
             



              -
             

              threatened preterm labor [
              
               10
              
              ]
             



              -
             

              vaso-occlusive crisis sickle cell disease [
              
               8
              
              ]
             


">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="3" row="2" text="



              -
             

              non- malignant tumors [
              
               31
              
              ]
             


">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
 </row>
 <row row="3">
  <cell col="0" row="3" text="
           P-LCR
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="1" row="3" text="
           15-35%
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="2" row="3" text="



              -
             

              immune thrombocytopenia purpura (ITP) [
              
               45
              
              ]
             



              -
             

              DM related retinopathy and nephropathy [
              
               22,23
              
              ]
             


">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="3" row="3" text="



              -
             

              myeloid insufficiency [
              
               45
              
              ]
             


">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
 </row>
 <row row="4">
  <cell col="0" row="4" text="
           PCT
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="1" row="4" text="
           0.22-0.24%
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="2" row="4" text="



              -
             

              acute cholecystitis [
              
               40
              
              ]
             



              -
             

              active Crohn’s Disease with low hs-CRP [
              
               17
              
              ]
             


">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
  <cell col="3" row="4" text="



              -
             

              immune thrombocytopenia purpura (ITP) [
              
               45
              
              ]
             


">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
  </cell>
 </row>
 <statements>
  <statement id="0" text="The value of 15-35% for normal range corresponds to the value of - myeloid insufficiency [ ] for conditions with platelet indices below normal range" type="">
  </statement>
  <statement id="1" text="The normal range is 15-35% when the conditions with platelet indices above normal range is - immune thrombocytopenia purpura (ITP) [ ] - DM related retinopathy and nephropathy [ 22,23 ]" type="">
  </statement>
  <statement id="2" text="The conditions with platelet indices below normal range is - non-complicated acute appendicitis [ ] - acute cholecystitis [ 40,41 ] - low-grade inflammation ex. rheumatoid arthritis [ ] - threatened preterm labor [ ] when the normal range is 7.2-11.7 fL" type="">
  </statement>
  <statement id="3" text="The conditions with platelet indices below normal range is - myeloid insufficiency [ ] when the conditions with platelet indices above normal range is - immune thrombocytopenia purpura (ITP) [ ] - DM related retinopathy and nephropathy [ 22,23 ]" type="">
  </statement>
  <statement id="4" text="The conditions with platelet indices above normal range is - DM related retinopathy and nephropathy [ 22,23 ] - ST-elevation myocardial infarction [ ] - acute cholecystitis [ ] - threatened preterm labor [ ] - vaso-occlusive crisis sickle cell disease [ ] when the conditions with platelet indices below normal range is - non- malignant tumors [ ]" type="">
  </statement>
  <statement id="5" text="The value of 0.22-0.24% for normal range corresponds to the value of - acute cholecystitis [ ] - active Crohn’s Disease with low hs-CRP [ ] for conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="6" text="The conditions with platelet indices above normal range is - immune thrombocytopenia purpura (ITP) [ ] - diabetes mellitus [ 18,19 ] - DM related retinopathy and nephropathy [ 22,23 ] - skeptic shock [ ] - heart disease [ ] - malignant tumors [ ] - complicated acute appendicitis [ ] when the conditions with platelet indices below normal range is - non-complicated acute appendicitis [ ] - acute cholecystitis [ 40,41 ] - low-grade inflammation ex. rheumatoid arthritis [ ] - threatened preterm labor [ ]" type="">
  </statement>
  <statement id="7" text="The conditions with platelet indices below normal range is - non- malignant tumors [ ] when the normal range is 8.3-56.6%" type="">
  </statement>
  <statement id="8" text="The normal range is 8.3-56.6% when the conditions with platelet indices above normal range is - DM related retinopathy and nephropathy [ 22,23 ] - ST-elevation myocardial infarction [ ] - acute cholecystitis [ ] - threatened preterm labor [ ] - vaso-occlusive crisis sickle cell disease [ ]" type="">
  </statement>
  <statement id="9" text="The value of - immune thrombocytopenia purpura (ITP) [ ] for conditions with platelet indices below normal range corresponds to the value of 0.22-0.24% for normal range" type="">
  </statement>
  <statement id="10" text="The conditions with platelet indices below normal range is - immune thrombocytopenia purpura (ITP) [ ] when the conditions with platelet indices above normal range is - acute cholecystitis [ ] - active Crohn’s Disease with low hs-CRP [ ]" type="">
  </statement>
  <statement id="11" text="The normal range is 7.2-11.7 fL when the conditions with platelet indices above normal range is - immune thrombocytopenia purpura (ITP) [ ] - diabetes mellitus [ 18,19 ] - DM related retinopathy and nephropathy [ 22,23 ] - skeptic shock [ ] - heart disease [ ] - malignant tumors [ ] - complicated acute appendicitis [ ]" type="">
  </statement>
  <statement id="12" text="The value of 8.3-56.6% for normal range corresponds to the value of - non-complicated acute appendicitis [ ] - acute cholecystitis [ 40,41 ] - low-grade inflammation ex. rheumatoid arthritis [ ] - threatened preterm labor [ ] for conditions with platelet indices below normal range" type="">
  </statement>
  <statement id="13" text="The value of - immune thrombocytopenia purpura (ITP) [ ] for conditions with platelet indices below normal range corresponds to the value of 15-35% for normal range" type="">
  </statement>
  <statement id="14" text="The value of - immune thrombocytopenia purpura (ITP) [ ] - diabetes mellitus [ 18,19 ] - DM related retinopathy and nephropathy [ 22,23 ] - skeptic shock [ ] - heart disease [ ] - malignant tumors [ ] - complicated acute appendicitis [ ] for conditions with platelet indices above normal range corresponds to the value of 8.3-56.6% for normal range" type="">
  </statement>
  <statement id="15" text="The value of - immune thrombocytopenia purpura (ITP) [ ] for conditions with platelet indices below normal range corresponds to the value of - immune thrombocytopenia purpura (ITP) [ ] - diabetes mellitus [ 18,19 ] - DM related retinopathy and nephropathy [ 22,23 ] - skeptic shock [ ] - heart disease [ ] - malignant tumors [ ] - complicated acute appendicitis [ ] for conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="16" text="The value of - acute cholecystitis [ ] - active Crohn’s Disease with low hs-CRP [ ] for conditions with platelet indices above normal range corresponds to the value of - myeloid insufficiency [ ] for conditions with platelet indices below normal range" type="">
  </statement>
  <statement id="17" text="The value of - non-complicated acute appendicitis [ ] - acute cholecystitis [ 40,41 ] - low-grade inflammation ex. rheumatoid arthritis [ ] - threatened preterm labor [ ] for conditions with platelet indices below normal range corresponds to the value of - acute cholecystitis [ ] - active Crohn’s Disease with low hs-CRP [ ] for conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="18" text="The conditions with platelet indices below normal range is - non- malignant tumors [ ] when the conditions with platelet indices above normal range is - immune thrombocytopenia purpura (ITP) [ ] - diabetes mellitus [ 18,19 ] - DM related retinopathy and nephropathy [ 22,23 ] - skeptic shock [ ] - heart disease [ ] - malignant tumors [ ] - complicated acute appendicitis [ ]" type="">
  </statement>
  <statement id="19" text="The value of - non- malignant tumors [ ] for conditions with platelet indices below normal range corresponds to the value of 0.22-0.24% for normal range" type="">
  </statement>
  <statement id="20" text="The conditions with platelet indices above normal range is - immune thrombocytopenia purpura (ITP) [ ] - diabetes mellitus [ 18,19 ] - DM related retinopathy and nephropathy [ 22,23 ] - skeptic shock [ ] - heart disease [ ] - malignant tumors [ ] - complicated acute appendicitis [ ] when the normal range is 0.22-0.24%" type="">
  </statement>
  <statement id="21" text="The value of - non-complicated acute appendicitis [ ] - acute cholecystitis [ 40,41 ] - low-grade inflammation ex. rheumatoid arthritis [ ] - threatened preterm labor [ ] for conditions with platelet indices below normal range corresponds to the value of 15-35% for normal range" type="">
  </statement>
  <statement id="22" text="The value of - non- malignant tumors [ ] for conditions with platelet indices below normal range corresponds to the value of 7.2-11.7 fL for normal range" type="">
  </statement>
  <statement id="23" text="The value of 7.2-11.7 fL for normal range corresponds to the value of - DM related retinopathy and nephropathy [ 22,23 ] - ST-elevation myocardial infarction [ ] - acute cholecystitis [ ] - threatened preterm labor [ ] - vaso-occlusive crisis sickle cell disease [ ] for conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="24" text="The value - immune thrombocytopenia purpura (ITP) [ ] belongs to conditions with platelet indices below normal range" type="">
  </statement>
  <statement id="25" text="The value - DM related retinopathy and nephropathy [ 22,23 ] - ST-elevation myocardial infarction [ ] - acute cholecystitis [ ] - threatened preterm labor [ ] - vaso-occlusive crisis sickle cell disease [ ] belongs to conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="26" text="The value - acute cholecystitis [ ] - active Crohn’s Disease with low hs-CRP [ ] belongs to conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="27" text="- myeloid insufficiency [ ] is in conditions with platelet indices below normal range" type="">
  </statement>
  <statement id="28" text="- non-complicated acute appendicitis [ ] - acute cholecystitis [ 40,41 ] - low-grade inflammation ex. rheumatoid arthritis [ ] - threatened preterm labor [ ] is in conditions with platelet indices below normal range" type="">
  </statement>
  <statement id="29" text="The value 0.22-0.24% belongs to normal range" type="">
  </statement>
  <statement id="30" text="The value - non- malignant tumors [ ] belongs to conditions with platelet indices below normal range" type="">
  </statement>
  <statement id="31" text="The value 7.2-11.7 fL belongs to normal range" type="">
  </statement>
  <statement id="32" text="The value - immune thrombocytopenia purpura (ITP) [ ] - diabetes mellitus [ 18,19 ] - DM related retinopathy and nephropathy [ 22,23 ] - skeptic shock [ ] - heart disease [ ] - malignant tumors [ ] - complicated acute appendicitis [ ] belongs to conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="33" text="- immune thrombocytopenia purpura (ITP) [ ] - DM related retinopathy and nephropathy [ 22,23 ] is in conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="34" text="The value 15-35% belongs to normal range" type="">
  </statement>
  <statement id="35" text="The value 8.3-56.6% belongs to normal range" type="">
  </statement>
  <statement id="36" text="- acute cholecystitis [ ] - active Crohn’s Disease with low hs-CRP [ ] is in conditions with platelet indices below normal range" type="">
  </statement>
  <statement id="37" text="The value 7.2-11.7 fL belongs to conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="38" text="The value - immune thrombocytopenia purpura (ITP) [ ] - diabetes mellitus [ 18,19 ] - DM related retinopathy and nephropathy [ 22,23 ] - skeptic shock [ ] - heart disease [ ] - malignant tumors [ ] - complicated acute appendicitis [ ] belongs to conditions with platelet indices below normal range" type="">
  </statement>
  <statement id="39" text="- immune thrombocytopenia purpura (ITP) [ ] - DM related retinopathy and nephropathy [ 22,23 ] is in conditions with platelet indices below normal range" type="">
  </statement>
  <statement id="40" text="- non-complicated acute appendicitis [ ] - acute cholecystitis [ 40,41 ] - low-grade inflammation ex. rheumatoid arthritis [ ] - threatened preterm labor [ ] is in normal range" type="">
  </statement>
  <statement id="41" text="15-35% is in conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="42" text="8.3-56.6% is in conditions with platelet indices below normal range" type="">
  </statement>
  <statement id="43" text="The value - myeloid insufficiency [ ] belongs to conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="44" text="The value - non- malignant tumors [ ] belongs to normal range" type="">
  </statement>
  <statement id="45" text="0.22-0.24% is in conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="46" text="The value - non-complicated acute appendicitis [ ] - acute cholecystitis [ 40,41 ] - low-grade inflammation ex. rheumatoid arthritis [ ] - threatened preterm labor [ ] belongs to conditions with platelet indices above normal range" type="">
  </statement>
  <statement id="47" text="The value - DM related retinopathy and nephropathy [ 22,23 ] - ST-elevation myocardial infarction [ ] - acute cholecystitis [ ] - threatened preterm labor [ ] - vaso-occlusive crisis sickle cell disease [ ] belongs to conditions with platelet indices below normal range" type="">
  </statement>
  <statement id="48" text="Normal range has all unique values." type="">
  </statement>
  <statement id="49" text="All the values in conditions with platelet indices above normal range are distinct." type="">
  </statement>
  <statement id="50" text="Conditions with platelet indices below normal range has no duplicate values." type="">
  </statement>
  <statement id="51" text="Normal range always has the same value." type="">
  </statement>
  <statement id="52" text="Conditions with platelet indices above normal range always has the same value." type="">
  </statement>
  <statement id="53" text="Conditions with platelet indices below normal range always has the same value." type="">
  </statement>
  <statement id="54" text="Normal range always has the same value." type="">
  </statement>
  <statement id="55" text="Conditions with platelet indices above normal range always has the same value." type="">
  </statement>
  <statement id="56" text="Conditions with platelet indices below normal range always has the same value." type="">
  </statement>
 </statements>
</Table 1>
